Any stock, in context
MEDICAMEQ · Healthcare
Medicamen Biotech Limited
Observation · 15 Oct 2026
How these are readMedicamen Biotech closed at ₹294.6 on 15 Oct 2026, 3.8% above its 200-day average and 5.5% above its 50-day average: above both lines. It sits 29.0% below its highest close of the past year, in the second fifth of its one-year range. Over three months it rose 23.8%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- Trade-for-trade (BE series)
- Thinly traded: under ₹1 crore a day
- vs 200-day
- +3.8%
- the long line
- vs 50-day
- +5.5%
- the short line
- From 52w high
- −29.0%
- ₹212.4₹447.7
- 3 months
- +23.8%
- sector median −2.7% · 17 of 146
Listed outside the Nifty indices · Healthcare (sector mapped from its industry) · BE series (trade-for-trade) · median traded value ₹0.58 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −0.42%
- 1W
- –
- 1M
- −7.15%
- 3M
- +23.78%
- YTD
- –
- 1Y
- −7.74%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.